Ashland (NYSE:ASH) Full Year 2024 Results
Key Financial Results
- Revenue: US$2.11b (down 3.6% from FY 2023).
- Net income: US$199.0m (up 19% from FY 2023).
- Profit margin: 9.4% (up from 7.7% in FY 2023).
- EPS: US$3.98 (up from US$3.17 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ashland EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.4%.
The primary driver behind last 12 months revenue was the Life Sciences segment contributing a total revenue of US$810.0m (38% of total revenue). Notably, cost of sales worth US$1.50b amounted to 71% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$426.0m (76% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of US$138.0m. Explore how ASH's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US.
Performance of the American Chemicals industry.
The company's shares are down 4.6% from a week ago.
Risk Analysis
It is worth noting though that we have found 2 warning signs for Ashland that you need to take into consideration.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:ASH
Ashland
Provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally.
Undervalued with adequate balance sheet and pays a dividend.
